Jymoral Tablet (Trypsin-Chymotrypsin) x30

ymoral Tablet contains Trypsin-Chymotrypsin (50,000 Armour units), a combination of proteolytic enzymes. This medication helps reduce inflammation, swelling, and pain associated with various inflammatory conditions, injuries, and post-surgical recovery.

Uses

Jymoral Tablet treats inflammatory conditions including sports injuries, sprains, fractures, and post-surgical swelling. It’s used for traumatic conditions, dental procedures, respiratory tract infections, ENT disorders, and as adjuvant therapy in wound healing, thrombophlebitis, and various surgical procedures.

Benefits

• Reduces inflammation and swelling effectively
• Accelerates healing after trauma or surgery
• Decreases pain by reducing inflammatory mediators
• Improves recovery time from soft tissue injuries
• Enhances absorption of antibiotics when co-administered
• Promotes faster resolution of hematomas
• Reduces stiffness in joints and muscles
• Improves mobility after injury or surgery
• Assists in resolving respiratory tract inflammation

How It Works

Trypsin and Chymotrypsin are proteolytic enzymes that break down proteins in damaged tissues. They reduce inflammation by decreasing inflammatory mediators, improving circulation to injured areas, and removing debris that impedes healing. These enzymes help dissolve blood clots, reduce edema, and accelerate the natural healing process.

Dosage

Take Jymoral tablets on an empty stomach, at least 30 minutes before meals or 2 hours after, with a full glass of water.

Duration of Action

Jymoral begins working within 1-2 hours of administration. Anti-inflammatory effects build up over 2-3 days of regular use. Maximum therapeutic benefit typically occurs after 5-7 days of consistent treatment. Effects generally persist for 4-6 hours after each dose.

Side Effects

Most patients tolerate Jymoral well. Occasional side effects include mild gastrointestinal disturbances such as nausea, indigestion, or stomach discomfort. Rare reactions include skin rash, itching, or allergic responses. These typically resolve upon discontinuation of the medication.

Warning

Avoid Jymoral in patients with bleeding disorders, severe liver disease, or recent major surgery with open wounds. Discontinue use and seek medical attention if experiencing unusual bleeding, severe stomach pain, or signs of allergic reaction. Not recommended during acute inflammation of the pancreas.

Pregnancy and Breastfeeding

Jymoral use during pregnancy and breastfeeding is not recommended unless clearly needed and prescribed by a physician. Insufficient data exists regarding safety during these periods. Consult healthcare provider for appropriate alternatives if anti-inflammatory treatment is required.

Interaction

• May enhance effects of anticoagulant medications
• Potential increased risk of bleeding with NSAIDs
• May enhance antibiotic penetration and effectiveness
• Possible interaction with anti-platelet medications
• May affect blood glucose levels in diabetic patients

Precaution

Use with caution in patients with history of stomach ulcers, kidney disease, or bleeding disorders. Monitor for signs of bleeding when used with other medications affecting coagulation. Discontinue use 2 weeks before any planned surgical procedure. Not recommended for children under 12 years without specific medical advice.

Important Information

Jymoral is a prescription medication containing proteolytic enzymes, not an analgesic. It works best when started promptly after injury or surgery. Store in a cool, dry place below 30°C. Therapeutic response may vary between individuals. Complete the prescribed course even if symptoms improve. If condition worsens or persists beyond expected recovery time, consult your healthcare provider.